Evidence map›Paper›PMID 40095466›Full record

ArticleJournal of clinical medicine2025

Clinical Significance of Antinuclear Antibodies in Patients with Rheumatoid Arthritis: From SETOUCHI-RA Registry.

Kazuhisa Nakano, Shunichi Fujita, Sumie Hiramatsu-Asano, Akiko Nagasu, Shoko Tsuji, Yuka Koide, Masatomo Yamada, Yo Mizuta, Masakatsu Ikeda, Hiroyasu Hirano and 1 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kazuhisa NakanoDepartment of Rheumatology, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Okayama, Japan.
Shunichi FujitaDepartment of Rheumatology, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Okayama, Japan.
Sumie Hiramatsu-AsanoDepartment of Rheumatology, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Okayama, Japan.
Akiko NagasuDepartment of Rheumatology, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Okayama, Japan.
Shoko TsujiDepartment of Rheumatology, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Okayama, Japan.
Yuka KoideDepartment of Rheumatology, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Okayama, Japan.
Masatomo YamadaDepartment of Rheumatology, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Okayama, Japan.
Yo MizutaDepartment of Rheumatology, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Okayama, Japan.
Masakatsu IkedaDepartment of Rheumatology, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Okayama, Japan.
Hiroyasu HiranoDepartment of General Internal Medicine 1, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Okayama, Japan.
Yoshitaka MoritaDepartment of Rheumatology, Kawasaki Medical School, 577 Matsushima, Kurashiki 701-0192, Okayama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antinuclear antibodiespulmonary complicationsrheumatoid arthritis

Identifiers

PMID40095466
PMCPMC11900084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.